GROSSO ® Reshaper FIH Trial: Three New Patients Treated in Barcelona

The GROSSO ® Reshaper First-In-Human (FIH) trial has progressed with the treatment of three new patient sat the Institute of Ocular Microsurgery (IMO) in Barcelona, Spain.

The procedures were performed by Principal Investigator Prof. Jose Luis Güell. Follow-up evaluations conducted post-surgery indicate that the GROSSO® Reshaper is well tolerated within the corneal tissue. These successful treatments marks a further step in assessing the clinical performance of the device and continues the planned enrollment for the study.